These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 18067995

  • 1. Myelin-basic protein-reactive specific CD4+ and CD8+ NK lymphocytes induce morphological changes in neuronal cell bodies and myelin sheaths: implications for multiple sclerosis.
    Zhang QY, Huang JH, Li HZ, Guo HT, Zhong YQ, Wang YM, Pei JM.
    Arch Med Res; 2008 Jan; 39(1):45-51. PubMed ID: 18067995
    [Abstract] [Full Text] [Related]

  • 2. The regulatory role of natural killer cells in multiple sclerosis.
    Takahashi K, Aranami T, Endoh M, Miyake S, Yamamura T.
    Brain; 2004 Sep; 127(Pt 9):1917-27. PubMed ID: 15229129
    [Abstract] [Full Text] [Related]

  • 3. CD8+ myelin peptide-specific T cells can chemoattract CD4+ myelin peptide-specific T cells: importance of IFN-inducible protein 10.
    Biddison WE, Cruikshank WW, Center DM, Pelfrey CM, Taub DD, Turner RV.
    J Immunol; 1998 Jan 01; 160(1):444-8. PubMed ID: 9552002
    [Abstract] [Full Text] [Related]

  • 4. A novel population of CD4+CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule.
    Vergelli M, Le H, van Noort JM, Dhib-Jalbut S, McFarland H, Martin R.
    J Immunol; 1996 Jul 15; 157(2):679-88. PubMed ID: 8752917
    [Abstract] [Full Text] [Related]

  • 5. Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals.
    Berthelot L, Laplaud DA, Pettré S, Ballet C, Michel L, Hillion S, Braudeau C, Connan F, Lefrère F, Wiertlewski S, Guillet JG, Brouard S, Choppin J, Soulillou JP.
    Eur J Immunol; 2008 Jul 15; 38(7):1889-99. PubMed ID: 18506883
    [Abstract] [Full Text] [Related]

  • 6. Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis.
    Burns J, Bartholomew B, Lobo S.
    Ann Neurol; 1999 Jan 15; 45(1):33-9. PubMed ID: 9894874
    [Abstract] [Full Text] [Related]

  • 7. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis.
    Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Zhang JZ.
    Ann Neurol; 2003 Feb 15; 53(2):189-97. PubMed ID: 12557285
    [Abstract] [Full Text] [Related]

  • 8. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
    Stinissen P, Raus J.
    Acta Neurol Belg; 1999 Mar 15; 99(1):65-9. PubMed ID: 10218096
    [Abstract] [Full Text] [Related]

  • 9. Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS.
    Musse AA, Harauz G.
    Int Rev Neurobiol; 2007 Mar 15; 79():149-72. PubMed ID: 17531841
    [Abstract] [Full Text] [Related]

  • 10. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
    Holmøy T.
    Minerva Med; 2008 Apr 15; 99(2):119-40. PubMed ID: 18431322
    [Abstract] [Full Text] [Related]

  • 11. Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis.
    Correale J, Villa A.
    J Neuroimmunol; 2008 Mar 15; 195(1-2):121-34. PubMed ID: 18234356
    [Abstract] [Full Text] [Related]

  • 12. Marburg's variant of multiple sclerosis correlates with a less compact structure of myelin basic protein.
    Beniac DR, Wood DD, Palaniyar N, Ottensmeyer FP, Moscarello MA, Harauz G.
    Mol Cell Biol Res Commun; 1999 Apr 15; 1(1):48-51. PubMed ID: 10329477
    [Abstract] [Full Text] [Related]

  • 13. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Vogt J, Paul F, Aktas O, Müller-Wielsch K, Dörr J, Dörr S, Bharathi BS, Glumm R, Schmitz C, Steinbusch H, Raine CS, Tsokos M, Nitsch R, Zipp F.
    Ann Neurol; 2009 Sep 15; 66(3):310-22. PubMed ID: 19798635
    [Abstract] [Full Text] [Related]

  • 14. Effect of gender on T-cell proliferative responses to myelin proteolipid protein antigens in patients with multiple sclerosis and controls.
    Greer JM, Csurhes PA, Pender MP, McCombe PA.
    J Autoimmun; 2004 Jun 15; 22(4):345-52. PubMed ID: 15120759
    [Abstract] [Full Text] [Related]

  • 15. The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis.
    Hedegaard CJ, Krakauer M, Bendtzen K, Sørensen PS, Sellebjerg F, Nielsen CH.
    Clin Immunol; 2008 Oct 15; 129(1):80-9. PubMed ID: 18653385
    [Abstract] [Full Text] [Related]

  • 16. Induction of experimental autoimmune encephalomyelitis in Lewis rats by a viral peptide with limited homology to myelin basic protein.
    Mao YS, Lu CZ, Wang X, Xiao BG.
    Exp Neurol; 2007 Aug 15; 206(2):231-9. PubMed ID: 17617406
    [Abstract] [Full Text] [Related]

  • 17. Dendritic cells loaded with apoptotic oligodendrocytes as a source of myelin T-cell epitopes in multiple sclerosis.
    Meloni F, Accapezzato D, Agresti C, Aloisi F, Ristori G, Salvetti M, Furlan R, Martino G, Barnaba V, Paroli M.
    Clin Immunol; 2008 Nov 15; 129(2):286-94. PubMed ID: 18753013
    [Abstract] [Full Text] [Related]

  • 18. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
    Dhib-Jalbut S.
    Neurology; 2007 May 29; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
    [Abstract] [Full Text] [Related]

  • 19. Early cellular events in multiple sclerosis. Intimations of an extrinsic myelinolytic antigen.
    Gay FW.
    Clin Neurol Neurosurg; 2006 Mar 29; 108(3):234-40. PubMed ID: 16364541
    [Abstract] [Full Text] [Related]

  • 20. Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.
    Trabattoni D, Saresella M, Pacei M, Marventano I, Mendozzi L, Rovaris M, Caputo D, Borelli M, Clerici M.
    J Immunol; 2009 Oct 15; 183(8):4984-93. PubMed ID: 19794071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.